Two-Stage Total Hip Arthroplasty for Primary Advanced Septic Arthritis of the Hip in Adults

Biomed Res Int. 2022 Apr 4:2022:8387465. doi: 10.1155/2022/8387465. eCollection 2022.

Abstract

Background: Comparing the outcomes of debridement and total hip arthroplasty (THA) with antibiotic-loaded spacer implantation and subsequent THA for the treatment of patients affected by primary advanced septic arthritis (SA) of the hip in adults.

Methods: All of the 20 patients (20 hips) underwent two-stage surgery. Nine patients were submitted to surgical debridement first and then THA (group 1), while 11 patients were treated with antibiotic-loaded spacer and subsequent THA (group 2). Patients were evaluated based on the recurrence of infection, Harris hip score, visual analogue scale (VAS) pain score, and leg length discrepancy.

Results: No cases of infection, deep vein thrombosis, death, and loosening of the hip prosthesis were observed during follow-up. The mean follow-up time was 29.09 ± 10.80 months in group 1 and 28.22 ± 14.80 months in group 2. Before the THA surgery, the mean leg length discrepancy was 2.80 ± 2.03 cm in group 1 and 0.50 ± 0.23 cm in group 2 (P < 0.05). In the latest follow-up, the Harris hip scores of patients were 90.33 ± 4.85 in group 1 and 94.36 ± 2.34 in group 2 (P < 0.05), respectively. There was no statistically significant difference in the VAS pain score of the hip between the two groups (P > 0.05).

Conclusions: Debridement and antibiotic-loaded spacer and subsequent THA were effective in eradicating the infection for advanced SA. However, antibiotic-loaded spacer and subsequent THA was superior for effectively maintaining the length of the lower limb and function of the hip.

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Arthritis, Infectious* / drug therapy
  • Arthritis, Infectious* / etiology
  • Arthritis, Infectious* / surgery
  • Arthroplasty, Replacement, Hip* / adverse effects
  • Hip Joint / surgery
  • Hip Prosthesis* / adverse effects
  • Humans
  • Pain
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents